Our results show that the treatment of highly metastatic SCCHN cells with NF-κB inhibitors significantly reduced cell invasion in vitro, while the apoptotic rates in highly metastatic cells have not been significantly increased compared with the lower metastatic Tca8113 cells. This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.